Promoter DNA Hypermethylation of the Cysteine Dioxygenase 1 (CDO1) Gene in Intraductal Papillary Mucinous Neoplasm (IPMN)-Reference-Cited by-同舟云学术

Promoter DNA Hypermethylation of the Cysteine Dioxygenase 1 (CDO1) Gene in Intraductal Papillary Mucinous Neoplasm (IPMN)

Published:2020-03-06 Issue:10 Volume:27 Page:4007-4016
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Fujiyama Yoshiki,Kumamoto Yusuke,Nishizawa Nobuyuki,Nakamoto Shuji,Harada Hiroki,Yokota Kazuko,Tanaka Yoko,Igarashi Kazuharu,Oiki Hironobu,Okuwaki Kosuke,Iwai Tomohisa,Kajita Sabine,Takahashi Hiroyuki,Tajima Hiroshi,Kaizu Takashi,Sasaki Jiichiro,Watanabe Masahiko,Yamashita Keishi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-020-08291-2.pdf

Reference43 articles.

1. Fernandez-del Castillo C, Adsay NV (2010) Intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology 139: 708–713.

2. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006; 6: 17–32.

3. Okabayashi T, Kobayashi M, Nishimori I, et al. Clinicopathological features and medical management of intraductal papillary mucinous neoplasms. J Gastroenterol Hepatol 2006; 21: 462–467.

4. Yopp AC, Katabi N, Janakos M, et al. Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma. Ann Surg 2011; 253: 968–974.

5. Mino-Kenudson M, Fernandez-del Castillo C, Baba Y, et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut 2011; 60: 1712–1720.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of CDO1 Gene Promoter Methylation in Tumors;PROG BIOCHEM BIOPHYS;2024

2. Molecular Pathology of Pancreatic Cystic Lesions with a Focus on Malignant Progression;Cancers;2024-03-18

3. Systematic review of challenging issues in pathology of intraductal papillary mucinous neoplasms;Pancreatology;2023-11

4. Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms;Clinical Epigenetics;2023-02-20

5. Epigenetic reprogramming in pancreatic premalignancy and clinical implications;Frontiers in Oncology;2023-02-16